Skip to Content

Gentaur Teclistamab – Anti-MS4A1 (CD20) Antibody

(0 review)
Targets MS4A1 (CD20) on B-cells. Suitable for B-cell malignancy studies, cell killing assays, and target validation.
1,234,567.00 € 1,234,567.00 € (Tax excluded)

0.00 € / Units
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Internal Reference: GMA-MS4A1
Display Name: [GMA-MS4A1] Gentaur Teclistamab – Anti-MS4A1 (CD20) Antibody